How to Help Your Patients Find Neupro in Stock: A Provider's Guide

For neurologists and other prescribers who manage Parkinson's disease and Restless Legs Syndrome, calls from patients unable to find Neupro (rotigotine transdermal patch) in stock have become increasingly common. As a brand-name-only medication with no generic equivalent in the US as of 2026, Neupro presents unique access challenges that go beyond what patients can navigate alone. This guide provides concrete strategies your practice can implement to proactively help patients maintain uninterrupted Neupro therapy.

Why Neupro Access Is a Provider-Level Issue

When a patient cannot find Neupro, the consequences are medical, not just logistical. Abrupt or unplanned discontinuation of a dopamine agonist can trigger dopamine agonist withdrawal syndrome (DAWS) — a serious condition with dysphoria, anxiety, sweating, insomnia, and in severe cases autonomic instability. PD patients may also experience sudden motor deterioration. This means that access failures for Neupro are clinical events that your office needs to respond to promptly — ideally before they happen.

Step 1: Proactively Educate Patients at the Time of Prescribing

The most effective intervention is at the point of prescribing. When you initiate or renew a Neupro prescription, include the following in your patient counseling:

• Warn that Neupro may not always be on the shelf at their pharmacy — especially for doses above 4 mg/24h.
• Instruct them to call ahead before assuming the pharmacy has it.
• Strongly advise refilling 7–10 days before the last patch runs out, not the day before.
• Provide the UCB savings card information for commercially insured patients and patient assistance contacts for uninsured patients.

Step 2: Build a Relationship With a Preferred Pharmacy

Many neurology practices work with one or two local pharmacies that reliably stock specialty neurological medications. Establishing a preferred pharmacy relationship for Neupro can provide significant value:

• Contact the pharmacy manager and alert them to your patient volume for Neupro; ask them to maintain standing inventory of the strengths you prescribe most frequently.
• Direct patients to this preferred pharmacy as the first stop for Neupro refills.
• For patients with swallowing difficulties or mobility limitations, arrange for mail-order pharmacy delivery.

Step 3: Recommend medfinder for Pharmacy Searches

For patients who are struggling to find Neupro, medfinder offers a direct solution. Patients provide their medication, dose, and ZIP code — medfinder then calls pharmacies near them to find which ones currently have Neupro in stock and can fill the prescription. Results are texted back to the patient. This removes the need for patients (many of whom have motor symptoms or cognitive challenges) to make multiple phone calls. Consider recommending medfinder in your patient handout materials for Neupro.

Step 4: Streamline Prior Authorization for Neupro

Prior authorization (PA) is a major cause of Neupro access delays. Most insurers require step therapy documentation showing that the patient tried and failed oral dopamine agonists (pramipexole and ropinirole) first. Streamline your PA process with these steps:

1. Document clearly in the chart: 'Patient tried pramipexole [date] — discontinued due to [side effect/inadequate response]' or 'Patient is unable to swallow oral medications due to [clinical reason].'
2. Submit the PA with diagnosis codes, documentation of prior therapy failures, and the clinical rationale for the patch specifically (continuous delivery, dysphagia, GI intolerance).
3. Use your EHR's PA workflow or assign a dedicated staff member to submit and track Neupro PAs given the frequency of the issue.
4. If PA is denied, request a peer-to-peer review. Neurologist-to-neurologist calls are effective for complex movement disorder cases.

Step 5: Establish a Protocol for Emergency Access

Create a written office protocol for when a patient calls unable to find Neupro:

1. Triage based on remaining supply: How many patches does the patient have left? 5+ patches = non-urgent. 1–3 patches = urgent. 0 patches = medical emergency.
2. For urgent or emergency cases: call the pharmacy directly (clinicians get faster answers than patients), check the wholesaler's availability, and prescribe an oral bridge if necessary.
3. Document the event and follow up at the next visit to discuss whether a supply strategy change (mail order, 90-day fills) is appropriate.

UCB's Patch Partnership Program: A Patient Support Resource

UCB offers the Patch Partnership Program™ for Neupro patients, which includes onboarding support, educational materials, and personalized support resources. Enrolling new patients in this program can improve adherence and early problem-solving around refill issues. The UCB ucbCARES® line (1-844-599-CARE) can also help patients navigate insurance, refill issues, and cost assistance. This is a valuable resource to mention at the time of the first Neupro prescription.

Summary: Provider Checklist for Neupro Access

• Counsel patients at prescribing: call ahead, refill early, do not stop abruptly
• Build preferred pharmacy relationships for Neupro stocking
• Recommend medfinder for patients who struggle to find Neupro
• Document clinical rationale at prescribing to ease prior authorization
• Have a written emergency access protocol for patients who are about to run out
• Enroll new patients in UCB's Patch Partnership Program and ucbCARES® support line